Lightnews — Scholar-powered news

Reposted by Otto Balsiger

Clinical & Experimental Immunology @ceijournal.bsky.social · 5d

Neuro-Behçet’s disease is a rare but severe manifestation of Behçet’s. This review highlights advances in diagnosis, biomarkers (IL-6, autoantibodies, BAFF), and immunopathogenesis.

🔗 https://bit.ly/4gZDyU0

2 1

Reposted by Otto Balsiger

British Society for Immunology @britsocimm.bsky.social · 2d

There’s still time to submit a late breaking abstract for #BSI25!

Poster presentations help you share your research, connect with experts and peers, and strengthen your professional profile.

Deadline: Wednesday 22 Oct ➡️ https://bit.ly/467fObc

3 7

Reposted by Otto Balsiger

British Society for Immunology @britsocimm.bsky.social · 3d

We're delighted to see immunologists once again recognised by the #NobelPrize! 🏆

Warm congratulations to the winners - their contributions have been vital in shaping our understanding of the immune system.

More here: www.immunology.org/news/british...

British Society for Immunology response to 2025 Nobel Prize for Physiology or Medicine | British Society for Immunology

www.immunology.org

13 49

Otto Balsiger @obalsiger.bsky.social · 6d

This is a great review looking at the complexity of liver transplantation and the critical immune mechanisms that aim to prevent graft rejection

@ceijournal.bsky.social

#LiverTransplant #Immunology

Clinical & Experimental Immunology @ceijournal.bsky.social · 6d

🩺 New review highlights immunological insights in liver transplantation from host–graft responses to biomarkers predicting rejection, emphasizing the quest for operational tolerance.

🔗 https://bit.ly/46xnt4l
##LiverTransplant #Immunology

2 1

Reposted by Otto Balsiger

British Society for Immunology @britsocimm.bsky.social · 8d

Limited spots left! Join our single cell & spatial omics #bioinformatics course starting Mon 20 Oct.

📚 You’ll get live training & access to self-paced materials (lecture recordings, cheat code, and R/command line workbooks).

BSI members get 50% off! bit.ly/4emxfIt

2 3

Otto Balsiger @obalsiger.bsky.social · 6d

She is great.
For me it was interesting to hear about the complexity of creating an inclusion criteria that properly subsets the patients who would benefit from trials.

1 1

Otto Balsiger @obalsiger.bsky.social · 6d

Only two months until #BSI25 - make sure you register

British Society for Immunology @britsocimm.bsky.social · 7d

Plenary at #BSI25: Challenging humans: infections, vaccines & allergens

Speakers: Prof Chris Chiu, Prof Isabelle Meyts and Prof Gabriel Victora.

Recent advances in human genetics & challenge studies are transforming how we study immunity.

Learn more: https://bit.ly/4pSCuVU

Otto Balsiger @obalsiger.bsky.social · 7d

Vaccines make such a difference..

#vaccines

Gavi @gavi.org · 7d

2024 also saw record country investment, with $255 million in co-financing for Gavi-supported vaccines.

From HPV to malaria, from zero-dose to economic growth, 2024 was Gavi’s most impactful year yet.

🔗 Read more: bit.ly/4q7j3sH

Gavi’s impact in 2024 in seven key statistics

In the time it takes you to read this article, six people’s lives will have been saved by Gavi-supported vaccines. Here are seven statistics on Gavi’s impact in 2024.

bit.ly

1

Otto Balsiger @obalsiger.bsky.social · 8d

This is a very interesting interview with Akiko Iwasaki

#LongCovid #immunology

Rhyothemis @rhyothemis.bsky.social · 10d

Interview with Yale immunologist Akiko Iwasaki | David Tuller

youtu.be/nJTaGD4fYz0

#LongCovid #MECFS #immunology #medicine #health

Interview with Yale immunologist Akiko Iwasaki

YouTube video by David M Tuller

youtu.be

1 3

Otto Balsiger @obalsiger.bsky.social · 8d

Well done Professor Jessica Teeling

I love this snakes and ladders game helping all ages learn how lifestyle choices cut dementia risk and protect their brain

British Society for Immunology @britsocimm.bsky.social · 9d

🧠 This #WorldAlzMonth, we celebrate Professor Jessica Teeling – winner of the BSI Public Engagement Award 2025!

Her giant snakes & ladders game helps all ages learn how lifestyle choices cut dementia risk and protect their brain.

Read more: bit.ly/3Ktiito

#AskAboutDementia

2

Reposted by Otto Balsiger

Clinical & Experimental Immunology @ceijournal.bsky.social · 11d

🔬 New study shows 2B4 (CD244) binds Staphylococcus aureus exotoxin SEB, driving allergic inflammation.

2B4 knockout mice had reduced inflammation → a potential therapeutic target.

Read here: https://bit.ly/4my2B1e
##Immunology #Staphylococcus #Inflammation

1 3

Reposted by Otto Balsiger

Immunotherapy Advances @imtadvances.bsky.social · 10d

🧬 Low MHC-I expression can help tumours evade the immune system.

Discover strategies to boost MHC-I and improve immunotherapy in paediatric and adult cancers. 🔬

Read: https://bit.ly/45vtfmp

#Immunotherapy #CancerResearch #MHCI

graphical abstract for Strategies to overcome low MHC-I expression in paediatric and adult tumours

1 1

Reposted by Otto Balsiger

Discovery Immunology @discovimmunol.bsky.social · 10d

📢 Call for Papers: Advances in Veterinary Immunology 🐾🧬

Submit original research & reviews on immune function in veterinary species, comparative immunology & One Health.

Deadline: March 2026

👉 https://bit.ly/46B1I2a
##Veterinary #Immunology #OneHealth #CFP

1 2

Reposted by Otto Balsiger

Discovery Immunology @discovimmunol.bsky.social · 13d

T-cell function is tightly linked to metabolism.

CARKL regulates cytokine outputs and migration by reprogramming metabolic pathways in T cells.

Read here🔗: https://bit.ly/3XDlIh6
##TCells #Immunology #Metabolism

1 4

Otto Balsiger @obalsiger.bsky.social · 13d

Do read this interesting article on plasma cells and their ability to produce antibodies against a variety of antigens, especially neoantigens, opening new avenues for personalised treatments

@imtadvances.bsky.social

Immunotherapy Advances @imtadvances.bsky.social · 13d

💡 Tumour-reactive plasma cells are emerging as powerful players in cancer immunotherapy!

Explore their role in antibody-based, personalized treatments. 🔬

Read: https://bit.ly/3SVZsMC

#Immunotherapy #CancerResearch #PlasmaCells

graphical abstract for Tumour-reactive plasma cells in antitumour immunity: current insights and future prospects

2

Otto Balsiger @obalsiger.bsky.social · 13d

Probably best to reach out to the authors for the next steps

Reposted by Otto Balsiger

Clinical & Experimental Immunology @ceijournal.bsky.social · 13d

🦴 New study identifies CFI, an NKT cell–related gene, as a promising biomarker in osteoarthritis.

Validated in patients & mouse models, CFI knockdown reduced inflammation.

🔗 https://bit.ly/42Lz1OT
##Osteoarthritis #Biomarkers #Immunology

1 1

Reposted by Otto Balsiger

Immunotherapy Advances @imtadvances.bsky.social · 13d

💥Open Access review: NK cells as cancer fighters!

From CAR-NK cells to checkpoint inhibitors, explore cutting-edge strategies to harness NK-cell immunity. 🔬

Read: https://bit.ly/4j8dKEW

#Immunotherapy #NKcells #CancerResearch

graphical abstract of Harnessing natural killer cell effector function against cancer

2 2

Reposted by Otto Balsiger

Sophie de Carné (she/her) @sdecarne.bsky.social · 13d

If you are looking for a postdoc position in a great lab with a fantastic PI, the Caswell Lab at UCL is recruiting 🙂

Debbie Caswell @caswelldrm.bsky.social · 13d

Our lab is hiring!

This is for a postdoctoral position @ucl.ac.uk in Respiratory Medicine.

Please check out the link for more details:
www.ucl.ac.uk/work-at-ucl/...

UCL – University College London

UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

www.ucl.ac.uk

2 4

Otto Balsiger @obalsiger.bsky.social · 14d

I think it could

1 1

Otto Balsiger @obalsiger.bsky.social · 16d

An interesting question: Could CD200R blockade enhance PD-1 therapy?

Check out this mouse study at @imtadvances.bsky.social

Immunotherapy Advances @imtadvances.bsky.social · 16d

Could CD200R blockade enhance PD-1 therapy?

A humanised mouse study found limited benefit in colorectal & lung cancer, but points to potential in CD200⁺ tumours.

🔗 https://bit.ly/4pdAtDw

#Immunotherapy #CancerResearch

1 2

Reposted by Otto Balsiger

BSI Clinical Immunology Professional Network @bsi-cipn.bsky.social · 16d

🚨 Last call! 🚨

The #BSICIPN25 abstract deadline is tomorrow (24 September). This is your final chance to secure your spot in the programme and share your work with the clinical immunology community.

👉 Submit now: bit.ly/4ne3EEP

2 2

Reposted by Otto Balsiger

British Society for Immunology @britsocimm.bsky.social · 23d

Spaces are filling fast! Register for our bioinformatics training starting Monday 20 October 👉 bit.ly/4emxfIt

British Society for Immunology @britsocimm.bsky.social · Sep 5

⏰ Don’t miss out! Our 'Single cell & spatial analysis' bioinformatics training course starts Monday 20 October.

✔️ Hands-on R training
✔️ 3,000+ past attendees
✔️ 9.5/10 rating

Only a few places left – secure yours today! https://bit.ly/4nnlTaN

4 4

Otto Balsiger @obalsiger.bsky.social · 19d

Discover the potential of DC3s for target therapies in this interesting paper @imtadvances.bsky.social

Immunotherapy Advances @imtadvances.bsky.social · 20d

Exploring the role of DC3s in solid tumours! These dendritic cells can boost anti-tumour immunity or contribute to immunosuppression depending on the TME.

Discover their potential for targeted therapies 👉 https://bit.ly/3T2blRg

#EMDS2025 #Immunotherapy #CancerResearch

1

Otto Balsiger @obalsiger.bsky.social · 21d

On this #HIVandAgeing Awareness Day, discover strategies to improve long-term immune health in this paper from @ceijournal.bsky.social

Clinical & Experimental Immunology @ceijournal.bsky.social · 21d

Persistent immune activation remains a challenge for people living with #HIV, even with viral control.

On #HIVandAgeing Awareness Day, discover strategies to improve long-term immune health

Read the study here👉 https://bit.ly/4g5VMm4